Wednesday, June 10, 2026

pharma ยท Anal Neoplasm ยท Lassa Fever ยท INO

INOVIO Pharmaceuticals

INOVIO Pharmaceuticals clinical programs โ€” 16 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO ยท NYSE Ticker
Company details
Status
Public
HQ
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
Employees
203
Programs
46
Drugs
8
Patents
75
Intelligence ยท Clinical Programs

INOVIO Pharmaceuticals projects

16 ClinicalTrials.gov programs sponsored by INOVIO Pharmaceuticals.

INOVIO Pharmaceuticals has 16 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CHRONVAC-Cยฎ

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C Virus Infection

    phase 2 small molecule active

    1 trial
  2. ChronVac-C + SOC

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C

    phase 2 small molecule active

    1 trial
  3. GLS-5300

    INOVIO PHARMACEUTICALS, INC.

    Healthy

    phase 2 mab completed

    2 trials
  4. HPV DNA Plasmids Therapeutic Vaccine VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Anal Intraepithelial Neoplasia

    phase 2 mab completed

    1 trial
  5. INO-3107

    INOVIO PHARMACEUTICALS, INC.

    Respiratory Papillomatosis

    phase 2 small molecule completed

    1 trial
  6. INO-3112

    INOVIO PHARMACEUTICALS, INC.

    Cervical Cancer

    phase 2 mab completed

    1 trial
  7. INO-3112

    INOVIO PHARMACEUTICALS, INC.

    Head and Neck Squamous Cell Cancer

    phase 2 mab completed

    1 trial
  8. INO-3112 vaccine

    INOVIO PHARMACEUTICALS, INC.

    Uterine Cervical Neoplasms

    phase 2 mab terminated

    1 trial
  9. INO-4700

    INOVIO PHARMACEUTICALS, INC.

    Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

    phase 2 small molecule completed

    1 trial
  10. INO-5401

    INOVIO PHARMACEUTICALS, INC.

    Glioblastoma

    phase 2 mab active

    1 trial
  11. INO-5401

    INOVIO PHARMACEUTICALS, INC.

    Urothelial Carcinoma

    phase 2 mab completed

    1 trial
  12. PENNVAX-GP

    INOVIO PHARMACEUTICALS, INC.

    HIV-1-infection

    phase 2 mab completed

    1 trial
  13. VGX 3100

    INOVIO PHARMACEUTICALS, INC.

    Cervical Intraepithelial Neoplasia

    phase 2 mab completed

    1 trial
  14. VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Anal Neoplasm

    phase 2 mab completed

    1 trial
  15. VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

    phase 2 mab completed

    1 trial
  16. p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine

    INOVIO PHARMACEUTICALS, INC.

    Leukaemia (Acute)

    phase 2 mab completed

    1 trial

Frequently asked questions

How many clinical projects does INOVIO Pharmaceuticals have?

16 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.